Illinois Municipal Retirement Fund boosted its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 114.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 34,460 shares of the company's stock after buying an additional 18,370 shares during the quarter. Illinois Municipal Retirement Fund's holdings in Option Care Health were worth $799,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. UMB Bank n.a. raised its position in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after purchasing an additional 346 shares during the last quarter. Lindenwold Advisors INC raised its holdings in Option Care Health by 5.4% in the 3rd quarter. Lindenwold Advisors INC now owns 9,548 shares of the company's stock valued at $299,000 after buying an additional 489 shares during the last quarter. Pacer Advisors Inc. boosted its position in Option Care Health by 2.2% during the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock worth $591,000 after buying an additional 537 shares during the period. Sheets Smith Wealth Management grew its holdings in Option Care Health by 2.4% during the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company's stock worth $553,000 after acquiring an additional 550 shares during the last quarter. Finally, Orion Portfolio Solutions LLC increased its position in Option Care Health by 2.3% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 28,232 shares of the company's stock valued at $884,000 after acquiring an additional 636 shares during the period. 98.05% of the stock is owned by institutional investors.
Option Care Health Trading Down 0.7 %
OPCH stock traded down $0.25 during mid-day trading on Friday, reaching $34.01. The company's stock had a trading volume of 1,610,533 shares, compared to its average volume of 1,591,663. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.85. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The business's 50 day moving average price is $29.61 and its 200 day moving average price is $28.18. The company has a market cap of $5.62 billion, a price-to-earnings ratio of 28.58, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33.
Insider Transactions at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.64% of the company's stock.
Wall Street Analyst Weigh In
OPCH has been the topic of a number of recent research reports. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $26.00 to $33.00 in a report on Monday, January 13th. JMP Securities reiterated a "market outperform" rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. JPMorgan Chase & Co. raised their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday. Barrington Research upped their target price on Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a report on Thursday, February 27th. Finally, Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and raised their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $33.00.
View Our Latest Stock Analysis on Option Care Health
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.